Table 1 Descriptive statistics for total sample and subgroup of those prescribed long-term anticholinergic medication (≥ 3 repeat prescriptions over 12 months)
Characteristic | Total | AC medications | ||
|---|---|---|---|---|
ID | GPop | ID | GPop | |
Population | 4,305 | 12,915 | 1,654 | 3,047 |
Sex | ||||
 Male | 2,504 (58.2%) | 7,512 (58.2%) | 925 (55.9%) | 1,628 (53.4%) |
 Female | 1,801 (41.8%) | 5,403 (41.8%) | 729 (44.1%) | 1,419 (46.6%) |
Age categories | ||||
 17–24 | 403 (9.4%) | 1,209 (9.4%) | 96 (5.8%) | 38 (1.3%) |
 25–34 | 811 (18.8%) | 2,433 (18.8%) | 224 (13.5%) | 172 (5.6%) |
 35–44 | 673 (15.6%) | 2,019 (15.6%) | 210 (12.7%) | 282 (9.3%) |
 45–54 | 965 (22.4%) | 2,895 (22.4%) | 418 (25.3%) | 726 (23.8%) |
 55–64 | 794 (18.4%) | 2,382 (18.4%) | 366 (22.1%) | 859 (28.2%) |
 65–74 | 464 (10.8%) | 1,392 (10.8%) | 235 (14.2%) | 645 (21.2%) |
 75 +  | 195 (4.5%) | 585 (4.5%) | 105 (6.4%) | 325 (10.7%) |
SIMD | ||||
 1-most deprived | 2,293 (53.3%) | 6,879 (53.3%) | 867 (52.4%) | 1,821 (59.8%) |
 2 | 848 (19.7%) | 2,544 (19.7%) | 331 (20.0%) | 605 (19.9%) |
 3 | 545 (12.7%) | 1,635 (12.7%) | 233 (14.1%) | 335 (11.0%) |
 4 | 349 (8.1%) | 1,047 (8.1%) | 135 (8.2%) | 173 (5.7%) |
 5-least deprived | 270 (6.3%) | 810 (6.3%) | 88 (5.3%) | 113 (3.7%) |